Antimicrobial Peptide Market

Chapter 1 Antimicrobial Peptide Market Overview

1.1 Antimicrobial Peptide Definition

1.2 Global Antimicrobial Peptide Market Size Status and Outlook (2019-2032)

1.3 Global Antimicrobial Peptide Market Size Comparison by Region (2019-2032)

1.4 Global Antimicrobial Peptide Market Size Comparison by Type (2019-2032)

1.5 Global Antimicrobial Peptide Market Size Comparison by Application (2019-2032)

1.6 Global Antimicrobial Peptide Market Size Comparison by Sales Channel (2019-2032)

1.7 Antimicrobial Peptide Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Antimicrobial Peptide Market Snapshot

2.2 Global Antimicrobial Peptide Market Volume & Revenue 2019-2025

2.3 Global Antimicrobial Peptide Market Differential Growth Potential Analysis by Type, 2019-2032 (USD Million)

2.4 Global Antimicrobial Peptide Market Differential Growth Potential Analysis by Application, 2019-2032 (USD Million)

2.5 Global Antimicrobial Peptide Market Differential Growth Potential Analysis by Sales Channels, 2019-2032 (USD Million)

2.6 Global Antimicrobial Peptide Market Differential Growth Potential Analysis by Region, 2019-2032 (USD Million)

Chapter 3 Antimicrobial Peptide Market Segment Analysis by Player

3.1 Global Antimicrobial Peptide Sales and Market Share by Player (2023-2025)

3.2 Global Antimicrobial Peptide Revenue and Market Share by Player (2023-2025)

3.3 Global Antimicrobial Peptide Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Antimicrobial Peptide Market Segment Analysis by Type

4.1 Global Antimicrobial Peptide Market by Type

4.1.1 Plant Antimicrobial Peptides

4.1.2 Microbial Antimicrobial Peptides

4.1.3 Animal Antimicrobial Peptides

4.2 Global Antimicrobial Peptide Sales and Market Share by Type (2019-2025)

4.3 Global Antimicrobial Peptide Revenue and Market Share by Type (2019-2025)

4.4 Global Antimicrobial Peptide Average Price by Type (2019-2025)

4.5 Leading Players of Antimicrobial Peptide by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Antimicrobial Peptide Market Segment Analysis by Application

5.1 Global Antimicrobial Peptide Market by Application

5.1.1 Pharmaceuticals

5.1.2 Feed Additives

5.1.3 Others

5.2 Global Antimicrobial Peptide Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Antimicrobial Peptide by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Antimicrobial Peptide Market Segment Analysis by Sales Channel

6.1 Global Antimicrobial Peptide Market by Sales Channel

6.1.1 Global Antimicrobial Peptide Market, by Direct Channel Market Analysis 2019-2032 (USD Million)

6.1.2 Global Antimicrobial Peptide Market, by Distribution Channel Market Analysis 2019-2032 (USD Million)

6.2 Global Antimicrobial Peptide Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Antimicrobial Peptide by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Antimicrobial Peptide Market Segment Analysis by Region

7.1 Global Antimicrobial Peptide Market Size and CAGR by Region (2019-2032)

7.2 Global Antimicrobial Peptide Sales and Market Share by Region (2019-2025)

7.3 Global Antimicrobial Peptide Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Antimicrobial Peptide Market Share by Type

7.4.3 North America Antimicrobial Peptide Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Antimicrobial Peptide Market Share by Type

7.5.3 Europe Antimicrobial Peptide Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Antimicrobial Peptide Market Share by Type

7.6.3 Asia-Pacific Antimicrobial Peptide Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Antimicrobial Peptide Market Share by Type

7.7.3 South America Antimicrobial Peptide Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Antimicrobial Peptide Market Share by Type

7.8.3 Middle East & Africa Antimicrobial Peptide Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.8.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Antimicrobial Peptide Players

8.1 AnaSpec

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 AMP Biotech

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Phoenix Biotech

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Novabiotics

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Chinese Peptide

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Ontores

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 GenScript

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Hycult Biotech

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Sunsmile

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Ruixing Biotechnology

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Zhongnong Yingtai Biotechnology

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Glam Technology

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 ProteLight Pharmaceutical & Biotechnology

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Antimicrobial Peptide

9.1 Industrial Chain of Antimicrobial Peptide

9.2 Upstream of Antimicrobial Peptide

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Antimicrobial Peptide

9.3.1 Leading Distributors/Dealers of Antimicrobial Peptide

9.3.2 Leading Consumers of Antimicrobial Peptide

Chapter 10. Global Antimicrobial Peptide Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Antimicrobial Peptide Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Antimicrobial Peptide Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Antimicrobial Peptide (2026-2032)

11.1 Global Antimicrobial Peptide Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Antimicrobial Peptide Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Antimicrobial Peptide Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Antimicrobial Peptide Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Antimicrobial Peptide Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Antimicrobial Peptide Import-Export, 2019-2025

12.2 Europe Antimicrobial Peptide Import-Export, 2019-2025

12.3 Asia Pacific Antimicrobial Peptide Import-Export, 2019-2025

12.4 South America Antimicrobial Peptide Import-Export, 2019-2025

12.5 Middle East & Africa Antimicrobial Peptide Import-Export, 2019-2025

Chapter 13. Demand-Supply Gap Analysis (If Applicable)

13.1 North America Antimicrobial Peptide Demand-Supply, 2019-2025

13.2 Europe Antimicrobial Peptide Demand-Supply, 2019-2025

13.3 Asia Pacific Antimicrobial Peptide Demand-Supply, 2019-2025

13.4 South America Antimicrobial Peptide Demand-Supply, 2019-2025

13.5 Middle East & Africa Antimicrobial Peptide Demand-Supply, 2019-2025

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources